NO962405L - Transdermalt terapeutisk system for forhindring av forgiftning med fosfororganiske nervegifter som omfatter et parasympatikomimetikum og et parasympatikolytikum - Google Patents
Transdermalt terapeutisk system for forhindring av forgiftning med fosfororganiske nervegifter som omfatter et parasympatikomimetikum og et parasympatikolytikumInfo
- Publication number
- NO962405L NO962405L NO962405A NO962405A NO962405L NO 962405 L NO962405 L NO 962405L NO 962405 A NO962405 A NO 962405A NO 962405 A NO962405 A NO 962405A NO 962405 L NO962405 L NO 962405L
- Authority
- NO
- Norway
- Prior art keywords
- therapeutic system
- transdermal therapeutic
- pct
- poisoning
- parasympatheticolytic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4342174A DE4342174C1 (de) | 1993-12-10 | 1993-12-10 | Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung |
PCT/EP1994/004048 WO1995015755A1 (fr) | 1993-12-10 | 1994-12-06 | Systeme therapeutique transdermique de prophylaxie de l'empoisonnement par des agents neurotoxiques organophosphores, constitue d'une association de principes actifs comprenant un agent parasympathomimetique et un agent parasympatholytique |
Publications (2)
Publication Number | Publication Date |
---|---|
NO962405D0 NO962405D0 (no) | 1996-06-07 |
NO962405L true NO962405L (no) | 1996-08-07 |
Family
ID=6504684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO962405A NO962405L (no) | 1993-12-10 | 1996-06-07 | Transdermalt terapeutisk system for forhindring av forgiftning med fosfororganiske nervegifter som omfatter et parasympatikomimetikum og et parasympatikolytikum |
Country Status (19)
Country | Link |
---|---|
US (1) | US5939095A (fr) |
EP (1) | EP0732924B1 (fr) |
JP (1) | JP3739789B2 (fr) |
KR (1) | KR100397361B1 (fr) |
AT (1) | ATE433339T1 (fr) |
CA (1) | CA2178603C (fr) |
CZ (1) | CZ291057B6 (fr) |
DE (2) | DE4342174C1 (fr) |
ES (1) | ES2329426T3 (fr) |
FI (1) | FI122131B (fr) |
HU (1) | HUT74432A (fr) |
IL (1) | IL111942A (fr) |
MY (1) | MY111715A (fr) |
NO (1) | NO962405L (fr) |
NZ (1) | NZ277492A (fr) |
PL (1) | PL314914A1 (fr) |
SK (1) | SK284356B6 (fr) |
WO (1) | WO1995015755A1 (fr) |
ZA (1) | ZA949842B (fr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7011843B2 (en) * | 1997-10-01 | 2006-03-14 | Lts Lohmann-Therapie Systeme Ag | Method for protecting a human being against health impairment by ingestion of a transdermal therapeutic system |
DE19743484C1 (de) * | 1997-10-01 | 1999-01-28 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit Schutz vor oraler Applikation und Verfahren zum Schutz einer Person vor Kontamination infolge unzulässiger oraler Applikation toxischer Inhaltsstoffe eines transdermalen therapeutischen Systems |
DE69912311T2 (de) * | 1998-12-24 | 2004-07-29 | Janssen Pharmaceutica N.V. | Galantamin-zusammensetzung mit gesteuerter freisetzung |
WO2003092606A2 (fr) * | 2002-05-01 | 2003-11-13 | Eisai Co., Ltd. | Inhibiteurs de cholinesterase pour prevenir les blessures causees par des produits chimiques |
DE10301851A1 (de) * | 2003-01-17 | 2004-07-29 | Lts Lohmann Therapie-Systeme Ag | Verfahren zur medikamentösen Prophylaxe gegen Vergiftungen durch Cholinesterase-Hemmer, sowie hierfür geeignete Wirkstoffe und Arzneimittel |
US20050013869A1 (en) * | 2003-07-18 | 2005-01-20 | Chaw Cheng Shu | Sustained release formulation for carbamates and a method therefor |
US8299062B2 (en) * | 2003-09-17 | 2012-10-30 | Franklin Volvovitz | Pharmaceutical compositions and methods for preventing, treating, or reversing neuronal dysfunction |
WO2005027905A1 (fr) * | 2003-09-19 | 2005-03-31 | The Secretary Of State For Defence | Compositions pharmaceutiques destinees au traitement d'un empoisonnement par un organophosphate |
AU2012200612B2 (en) * | 2004-09-24 | 2014-11-20 | The Government Of The United States, As Represented By The Secretary Of The Army | Method of treating organophosphorus poisoning |
ES2662868T3 (es) * | 2004-09-24 | 2018-04-10 | University Of Maryland, Baltimore | Procedimiento para el tratamiento de una intoxicación por una sustancia organofosforada |
US9132135B2 (en) | 2004-09-24 | 2015-09-15 | University Of Maryland, Baltimore | Method of treating organophosphorous poisoning |
WO2008022365A2 (fr) * | 2006-08-24 | 2008-02-28 | Sanochemia Ltd. | Agent servant à influencer les effets de composés organophosphorés et utilisation de galanthamine, de ses dérivés et analogues pour la fabrication d'un tel agent |
GB0809905D0 (en) * | 2008-06-02 | 2008-07-09 | Secr Defence | A Transdermal drug delivery device |
RU2612506C2 (ru) | 2011-03-03 | 2017-03-09 | Импел Ньюрофарма Инк. | Устройство для назальной доставки лекарственных средств |
WO2020112766A1 (fr) * | 2018-11-26 | 2020-06-04 | Steven Hoffman | Compositions et méthodes de traitement d'une exposition à des agents neurotoxiques |
CA3140042A1 (fr) | 2019-05-14 | 2020-11-19 | Tyme, Inc. | Compositions et methodes de traitement du cancer |
US10905698B1 (en) | 2020-05-14 | 2021-02-02 | Tyme, Inc. | Methods of treating SARS-COV-2 infections |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3797494A (en) * | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
US3996934A (en) * | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
US3742951A (en) * | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
AR207805A1 (es) * | 1975-02-06 | 1976-10-29 | Alza Corp | Substrato apropiado para formar apositos para la dispensacion continua de escopolamina base por via transdermica |
US4031894A (en) * | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
US4278679A (en) * | 1980-05-01 | 1981-07-14 | Chromalloy American Corporation | Combination of two or more drugs in a single dosage form wherein one of the drugs is a physostigmine compound |
US4952586A (en) * | 1982-08-27 | 1990-08-28 | The Regents Of The University Of California | Edrophonium-atropine composition and therapeutic uses thereof |
DE3315272C2 (de) * | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
IL72684A (en) * | 1984-08-14 | 1989-02-28 | Israel State | Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs |
US5106831A (en) * | 1987-08-13 | 1992-04-21 | State Of Israel, Represented By The Prime Minister's Office, Israel Institute For Biological Research | Pharmaceutical composition comprising a spiro oxathiolon/quinuclidine and method of treating senile dementia |
US4981858A (en) * | 1987-08-13 | 1991-01-01 | State Of Israel, Represented By The Prime Minister's Office, Israel Institute For Biological Research | Optical isomers |
DE3843238C1 (fr) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
DE3843239C1 (fr) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
WO1991015176A1 (fr) * | 1990-04-06 | 1991-10-17 | Pharmetrix Corporation | Dispositif et procede d'administration amelioree de physostigmine |
DE4115558A1 (de) * | 1991-05-13 | 1992-11-19 | Dresden Arzneimittel | Prophylaktisches antidot gegen phosphororganische gifte |
GB9118028D0 (en) * | 1991-08-21 | 1991-10-09 | Secr Defence Brit | Improved transdrmal formulations |
-
1993
- 1993-12-10 DE DE4342174A patent/DE4342174C1/de not_active Ceased
-
1994
- 1994-12-06 HU HU9601569A patent/HUT74432A/hu unknown
- 1994-12-06 CA CA002178603A patent/CA2178603C/fr not_active Expired - Fee Related
- 1994-12-06 KR KR1019960702988A patent/KR100397361B1/ko not_active IP Right Cessation
- 1994-12-06 ES ES95903793T patent/ES2329426T3/es not_active Expired - Lifetime
- 1994-12-06 WO PCT/EP1994/004048 patent/WO1995015755A1/fr active IP Right Grant
- 1994-12-06 EP EP95903793A patent/EP0732924B1/fr not_active Revoked
- 1994-12-06 DE DE59410461T patent/DE59410461D1/de not_active Expired - Lifetime
- 1994-12-06 SK SK739-96A patent/SK284356B6/sk not_active IP Right Cessation
- 1994-12-06 CZ CZ19961684A patent/CZ291057B6/cs not_active IP Right Cessation
- 1994-12-06 PL PL94314914A patent/PL314914A1/xx unknown
- 1994-12-06 JP JP51596695A patent/JP3739789B2/ja not_active Expired - Fee Related
- 1994-12-06 NZ NZ277492A patent/NZ277492A/en not_active IP Right Cessation
- 1994-12-06 AT AT95903793T patent/ATE433339T1/de not_active IP Right Cessation
- 1994-12-06 US US08/656,208 patent/US5939095A/en not_active Expired - Lifetime
- 1994-12-08 MY MYPI94003278A patent/MY111715A/en unknown
- 1994-12-09 IL IL111942A patent/IL111942A/en not_active IP Right Cessation
- 1994-12-09 ZA ZA949842A patent/ZA949842B/xx unknown
-
1996
- 1996-05-27 FI FI962220A patent/FI122131B/fi not_active IP Right Cessation
- 1996-06-07 NO NO962405A patent/NO962405L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HU9601569D0 (en) | 1996-08-28 |
DE59410461D1 (de) | 2009-07-23 |
NZ277492A (en) | 1998-01-26 |
JP3739789B2 (ja) | 2006-01-25 |
ZA949842B (en) | 1995-09-01 |
IL111942A (en) | 1998-02-08 |
KR960706339A (ko) | 1996-12-09 |
SK284356B6 (sk) | 2005-02-04 |
PL314914A1 (en) | 1996-09-30 |
IL111942A0 (en) | 1995-03-15 |
US5939095A (en) | 1999-08-17 |
EP0732924B1 (fr) | 2009-06-10 |
SK73996A3 (en) | 1997-01-08 |
FI122131B (fi) | 2011-09-15 |
ES2329426T3 (es) | 2009-11-25 |
HUT74432A (en) | 1996-12-30 |
JPH09506360A (ja) | 1997-06-24 |
CZ291057B6 (cs) | 2002-12-11 |
WO1995015755A1 (fr) | 1995-06-15 |
DE4342174C1 (de) | 1995-05-11 |
EP0732924A1 (fr) | 1996-09-25 |
MY111715A (en) | 2000-11-30 |
AU1273395A (en) | 1995-06-27 |
FI962220A0 (fi) | 1996-05-27 |
CZ168496A3 (en) | 1996-11-13 |
CA2178603A1 (fr) | 1995-06-15 |
ATE433339T1 (de) | 2009-06-15 |
CA2178603C (fr) | 2005-08-09 |
KR100397361B1 (ko) | 2004-03-24 |
NO962405D0 (no) | 1996-06-07 |
AU703692B2 (en) | 1999-04-01 |
FI962220A (fi) | 1996-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO962405D0 (no) | Transdermalt terapeutisk system for forhindring av forgiftning med fosfororganiske nervegifter som omfatter et parasympatikomimetikum og et parasympatikolytikum | |
FI954990A0 (fi) | Aktiiviainetta sisältävä transdermaalinen valmiste | |
Sellin | The pharmacological mechanism of botulism | |
UA35567C2 (uk) | Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату | |
PT732926E (pt) | Formulacao farmaceutica para a profilaxia ou o pre-tratamento do envenenamento por inibidores de colinesterase organofosforados | |
AU8561298A (en) | Remedies for complications of diabetes | |
NO962655L (no) | Deutrerte virkestoffer i transdermal applikasjon | |
PT862454E (pt) | Novas utilizacoes de ctla-8 de mamifero e reagentes relacionados | |
PT695303E (pt) | Sais de piridinio e seu emprego no combate as bacterias helicobacter | |
AU7941294A (en) | Composition for the treatment or prevention of herpes | |
DE59510583D1 (de) | Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid | |
FI884041A (fi) | Desinfiointikoostumus stafylokokkien tappamiseksi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |